Weng Kung is a Principal Investigator and Research Group Leader (2017) at International Iberian Nanotechnology Laboratory. His research group interest focuses on developing and translating technological innovations (e.g., nuclear magnetic resonance, electron spin resonance, spintronic, Raman spectroscopic) for the next generation of precision (molecular) medicine (or agriculture), which enables in-situ, rapid, high-throughput, and multidimensional molecular phenotyping in (preferably) functional manner. Some of his team successful projects validated in clinical (and field) setting include the rapid and label-free malaria screening, high-throughput molecular phenotyping of oxidative stress in diabetes mellitus, sub-stratification of endometriosis, and multidimensional spectroscopy for molecular phenotyping in hemoglobinopathies.

Weng Kung received his bachelor degree in Theoretical Physics from University of Malaya, Malaysia (2003), and pursued his Ph.D. in the Spin Dynamics of Nuclear Magnetic Resonance from Osaka University, Japan (2008). He then became a Junior Investigator at BioSyM-SMART, Massachusetts Institute of Technology (MIT) by winning the highly competitive SMART Postdoctoral Fellowship (2009-2013) and subsequently promoted to the independent role of Research Scientist (2014-2015). SMART Centre is the first research institution established outside Boston, under the joint venture between MIT and National Research Foundation of Singapore. He then served as Senior Research Scientist (2015-2017) assisted in the setting up of NTU Institute of Health Technologies, which promotes the translation of technological innovation into local medical healthcare system, and promotes industry partnership.

He holds several key (joint) patents and authored several seminal papers which appeared in Nature Medicine, Scientific Reports, Review of Scientific Instrumentation, Advanced Healthcare Materials, Lab-on-Chip and attracted worldwide press coverages (e.g., The Guardian, The Strait Times, Asian Scientist Magazine, Nature). Weng Kung is the recipient of several awards such as Japan Ministry of Science and Technology Scholar, SMART MIT Postdoctoral Fellowship, SMART MIT Technology Ignition, and Bronze medal in Translational Technology Pitching Forum, Singapore. In 2014, Weng Kung was listed as one of the Top 100 Global Thinkers, in recognition of his team disruptive technology under the Category Healers. Top 100 Global Thinkers is an annual list published by Foreign Policy magazine, which recognizes the world’s pre-eminent thought leaders and
public intellectuals. Among other previous recipients were Elizabeth Holmes, Jennifer Doudna, Mark Zuckerberg, Barack Obama and Jack Ma.

• W.K. Peng*, T.F. Kong, C.S. Ng, et. al.,
  Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis.
  Nature Medicine 20, 1069-1073 (2014)

• J. Han & W.K. Peng
  Commentary: Considerations regarding Micromagnetic resonance relaxometry technique for rapid label-free malaria diagnosis.
  Nature Medicine 21, 1387 (2015)

• W.K. Peng*, Chen, L. & J. Han
  Development of miniaturized, portable magnetic resonance relaxometry system for point-of-care medical diagnosis.
  Review of Scientific Instruments 83, 095115 (2012)

• R.J. Toh, W.K. Peng, J. Han & M. Pumera.
  Direct In Vivo Electrochemical Detection of Haemoglobin in Red Blood Cells.
  Sci Rep. 4: 6209 (2014)

• T.F. Kong, W.K. Peng, L.T. Dung, N.T. Nguyen, & J. Han.
  Adhesive-based liquid metal radio-frequency microcoil for magnetic resonance relaxometry measurement.
  Lab on a Chip 12, 287-294 (2012).

• W.K. Peng*, L. Chen, B. Boehm & T.P. Loh.
  Molecular Phenotyping of Oxidative Stress in Diabetes Mellitus with Novel micro Magnetic Resonance Relaxometry.
  (Under-reviewed, 2017).

• W.K. Peng*, D. Lim, T.T. Ng & T.P. Loh.
  Multidimensional T1-T2 Correlational Spectroscopy for Rapid and Label-free
  Molecular Phenotyping in Hemoglobinopathies.
  (Under-reviewed, 2017).